China NMPA approves InnoCare Pharma’s orelabrutinib for first-line treatment of patients with CLL/SLL: Beijing Monday, April 28, 2025, 12:00 Hrs [IST] InnoCare Pharma, a leading ...

EMA recommends marketing approval for Amgen Europe’s Tepezza to treat adults with moderate to severe thyroid eye disease: Amsterdam, The Netherlands Monday, April 28, 2025, 11:0 ...

Medtronic receives US FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure lead: Galway, Ireland Monday, April 28, 2025, 10:00 Hrs [IST] Medtronic pl ...

NABL issues updated accreditation criteria for biobanks aligned with ISO 20387:2018: Shardul Nautiyal, Mumbai Monday, April ...

Health informatics and medical AI are making waves in job market: Nandita Vijayasimha, Bengaluru Monday, April 28, 2025, 08:00 Hrs [IST] Indian hiring companies note that health i ...

Kerala IPA initiates training programmes for B Pharm students to make them industry professionals: Peethaambaran Kunnathoor, Chennai Monday, April 28, 2025, 08:00 Hrs [IST] To sup ...

PCI to initiate new assessment and rating system for pharmacy institutions: Gireesh Babu, New Delhi Monday, April 28, 2025, ...

Hyderabad tops student pass outs among the six NIPERs launched in 2007: Gireesh Babu, New Delhi Monday, April 28, 2025, 08:00 Hrs [IST] Among the six National Institutes of Pharma ...

Zealand Pharma begins patient enrolment in phase 2b ZUPREME-2 trial of petrelintide in people with overweight or obesity and type 2 diabetes: Copenhagen, Denmark Saturday, April 2 ...

Debiopharm, Oncodesign Services announce license agreement for use of AbYlink technology for pre-clinical services: Martigny, Switzerland Saturday, April 26, 2025, 17:00 Hrs [IST] ...

Gosselies, Belgium Saturday, April 26, 2025, 16:00 Hrs [IST] ...

Basilea Pharmaceutica receives CHF 1.7 mn milestone payment from Asahi Kasei Pharma for strong sales of Cresemba in Japan: Allschwil, Switzerland Saturday, April 26, 2025, 15:00 H ...